Teva schizophrenia drug Phase III results excite analysts

Teva  credit: Cineberg/Shutterstock
Teva credit: Cineberg/Shutterstock

Evercore ISI analyst Umer Raffat believes that sales could amount to more than $1 billion annually.

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) saw its share price jump 12.8% yesterday, amid high trading volume, to a five-year high. The share price of $15.74 gave a market cap of $17.8 billion, after the company reported first quarter results of $3.81 billion revenue, a GAAP net loss of $139 million and a non-GAAP net profit of $548 million.

Investors liked the fact that Teva reaffirmed its annual outlook and beat the revenue guidance for the quarter due to better than expected sales in the US generics market. The share surged even though earnings per share was lower than analysts' expectations.

But what particularly enthused the market was the positive Phase III clinical trial results of Olanzapine LAI, which Teva is developing with Medincell, and which is injected once a month for the treatment of schizophrenia. Teva CEO Richard Francis said that the trial had met its end points and there was a good likelihood that it would allow long-term effective treatment for schizophrenia, without PDSS side-effects.

If the drug reaches the market it could significantly contribute to Teva's results. Evercore ISI analyst Umer Raffat believes that sales could amount to more than $1 billion annually, which would enhance Teva's EBITDA. He says that Teva's story today is significantly different than several years ago.

UBS believes that annual sales of Olanzapine could reach $875 million by 2030. The Swiss bank's analysts' give a "Buy" recommendation for Teva's share and a price target of $19, a 20.7% upside on the company's current share price. UBS sees Teva's 2024 revenue reaching $16.1 billion with EBITDA of $4.9 billion, higher than the analysts' consensus and in the middle range of Teva's own outlook.

Jefferies gives Teva a target price of $17, an 8% upside for the Israeli pharmaceutical company, and a "Buy" recommendation. Jefferies' analysts think that Teva's share is undervalued and its current price attributes little credit to its product pipeline, probably due to Teva's history in recent years. "We think the market has not fully digested Teva's change in DNA," they write. "We believe that today's announcement (about the trial results) and further announcements in the future about the product pipeline can reflect a change."

Leader Capital Markets yesterday raised the price target for Teva from $16 to $18 (14.4% higher than the current price) with an "Outperform" recommendation. According to Leader research department director Sabina Levy, Teva's revenue in the first quarter was higher than expected, thanks among other things to the strong performance of the generics business and growth of about 8% in the US, and in addition, Teva presented higher than expected revenue from the sale of branded drug Austedo.

Published by Globes, Israel business news - en.globes.co.il - on May 9, 2024.

© Copyright of Globes Publisher Itonut (1983) Ltd., 2024.

Teva  credit: Cineberg/Shutterstock
Teva credit: Cineberg/Shutterstock
US President Donald Trump  credit: Reuters/Leah Millis Israel moves to avoid Trump's tariffs axe

Minister of Finance Bezalel Smotrich has signed an order canceling all tariffs on imports from the US. The impact will mostly be on agricultural produce.

Forbes Rich List credit: Shutterstock Maslowski Marcin Wiz founders ranked in Forbes 2025 Rich List

There are a few dozen Israelis listed in the 2025 Forbes Real-Time Billionaires List including Wiz founders Assaf Rappaport, Yinon Costica, Roy Reznik and Ami Luttwak.

SatixFy CEO Nir Barkan credit: Ariel Barkan Canada's MDA Space to buy Israeli satcom co SatixFy

MDA Space will pay $269 million for the Israeli company, including taking on a $76 million debt and a 75% premium on SatixFy's closing price on Nasdaq yesterday.

Raising dollars credit: Shutterstock Israeli startups raised over $1b in March

Israeli privately-held tech companies have raised $2.1 billion in the first three months of 2025, according to IVC-LeumiTech, up 24% from the corresponding quarter of 2024.

Terminal 1 credit: Personal image Terminal 1 reopening revives Israel low-cost fare options

With the opening of the terminal for international flights, the Irish low-cost airline Ryanair has returned to Israel and with it, double-digit US dollar round-trip fares.

Arkady Volozh  credit: Shlomi Yosef Analysts see Israel-linked Nebius challenging CoreWeave

Nebius, founded by Yandex founder Arkady Volozh, operates in CoreWeave's AI server market, but is growing "more rationally", and has far less debt.

Bezalel Smotrich and Amir Yaron credit: Knesset Spokesperson and Tali Bogdanovsky Retail chains, credit card cos could soon act as banks

Israel's financial regulators have proposed that supermarket chains, credit card companies and investment houses will be able to accept deposits and offer credit.

Elbit Systems rocket launcher  credit: Elbit Systems Elbit Systems wins $130m European rocket order

The order is for the supply of rockets for Elbit's Precise and Universal Launching System (PULS), which has an effective range of up to 300 kilometers.

Nvidia VP Ali Kani credit: Nvidia Nvidia intensifies efforts to compete with Mobileye

"Globes" talks to Nvidia VP and automotive team head Ali Kani about the chipmaker's autonomous vehicle activities and assesses the threat to Mobileye.

Fitch ratings agency credit: Shutterstock Fitch reaffirms Israel's A rating with negative outlook

The ratings agency said, "The negative outlook reflects rising public debt, domestic political and governance challenges and uncertain prospects for the conflict in Gaza."

Tamar rig credit: PR Sovereign Wealth Fund earned handsome returns in 2024

Israel's Sovereign Wealth Fund, known as the Citizens' Fund, had assets worth about $2 billion at the end of 2024, the Ministry of Finance reports.

Fencing goes up Petah Tikva's Segula neighborhood  credit: NTA Work on Metro to begin in Petah Tikva

The first work on the Tel Aviv Metropolitan underground railways system will begin on the M2 line depot in Petah Tikva.

Startups credit: Shutterstock/NicoElNino IVC-LeumiTech: Tech fund raising jumps 24% in Q1

Israeli privately-held tech companies raised $2.13 billion in the first quarter of 2025, up 24% from the corresponding quarter of 2024, but down 12% from the preceding quarter.

Miri Regev and Yitzhak Rochberger credit: Yediot Ahronot/ Reuven Kapuchinsky and Amit Shabi Ramat Hasharon wants railway station for the Mossad

Ramat Hasharon is pushing for a station in Glilot neat the Mossad headquarters, even though a new station is also planned for Glilot South, 1.6 kilometers away.

Prime Minister Benjamin Netanyahu credit: Reuven Kastro Police call Netanyahu for testimony as aides arrested

Jonatan Urich and Eli Feldstein are being held over alleged payments received from Qatar while working in the prime minister's bureau.

Highcon chairperson Shlomo Nimrodi  credit: PR Packaging tech co Highcon winding down

The company, which numbers Benny Landa and JVP among its investors, is laying off most of its workforce, having lost 99.9% of its value since its flotation.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018